Use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors among medicaid beneficiaries with AIDS

Keyphrases

• Protease Inhibitors 100%
• Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) 100%
• Medicaid Beneficiaries 100%
• Medicaid Waiver 40%
• Waiver Program 40%
• Antiretroviral Therapy 20%
• AIDS/HIV 20%
• New Jersey 20%
• Treatment Efficacy 20%
• Community-based 20%
• Barriers to Care 20%
• Patient Characteristics 20%
• Injection Drug Users 20%
• New Antiretrovirals 20%
• Early Years 20%
• Surveillance Data 20%
• Sociodemographic Differences 20%
• Inhibitor Therapy 20%
• Claims Data 20%
• Health Insurance Coverage 20%
• Usage Patterns 20%
• Home-based 20%
• Financial Barriers 20%
• Sociodemographic Subgroups 20%
• Inhibitor Treatment 20%

Medicine and Dentistry

• Proteinase Inhibitor 100%
• Nonnucleoside Reverse Transcriptase Inhibitor 100%
• Medicaid 100%
• Acquired Immune Deficiency Syndrome 100%
• Patient Characteristics 20%
• Drug Administration 20%
• HIV/AIDS 20%
• Artificial Intelligence 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Proteinase Inhibitor 100%
• Nonnucleoside Reverse Transcriptase Inhibitor 100%
• Acquired Immune Deficiency Syndrome 100%
• HIV 20%